GILUTENSIN
Swiss trademark · 387313 · Word mark · Deleted
Register entry
- Registration number
- 387313
- Application number
- 00078/1991
- Status
- Deleted
- Type
- Word mark
- Filed
- Jan 7, 1991
- Registered
- Nov 1, 1991
- Published
- Dec 10, 1991
- Deleted
- Aug 8, 2011
- Reason
- Not renewed
- Source
- Swissreg
Goods and services
Pharmaceuticals
Arzneimittel, insbesondere Herz-Kreislauf-Präparate.
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Aug 8, 2011
Deleted, not renewed
Published in Swissreg on 08.08.2011
- Aug 2, 2011
Agent’s address changed
- Representative
- Novagraaf Switzerland S.A., Avenue du Pailly 25, 1220 Les Avanchets → Novagraaf Switzerland SA, Chemin de l'Echo 3, 1213 Onex
Published in Swissreg on 02.08.2011
- Oct 1, 2010
Holder’s address changed
- Owner
- Solvay Pharmaceuticals GmbH, Hans-Böckler-Allee 20, 30173 Hannover, Germany → Abbott Products GmbH, Hans-Böckler-Allee 20, 30173 Hannover, Germany
Published in Swissreg on 01.10.2010
- Oct 1, 2010
Agent entered
- Representative
- Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich → Novagraaf Switzerland S.A., Avenue du Pailly 25, 1220 Les Avanchets
Published in Swissreg on 01.10.2010
- Aug 20, 2007
Agent’s address changed
- Representative
- Isler & Pedrazzini AG, Patentanwälte, Stampfenbachstrasse 48, Postfach 6940, 8006 Zürich → Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich
Published in the SOGC no. 159 of 20.08.2007
- Aug 7, 1997
Holder’s address changed
- Owner
- Kali-Chemie Pharma, Gesellschaft mit beschränkter, Haftung, Hans-Böckler-Allee 20, D-3000 Hannover 1, Germany → Solvay Pharmaceuticals GmbH, Hans-Böckler-Allee 20, 30173 Hannover, Germany
Published in the SOGC no. 149 of 07.08.1997
- Dec 10, 1991
Registered
Published in the SOGC no. 239 of 10.12.1991
Parties
The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.